We have data on 64 companies that use Merge eClinical OS. The companies using Merge eClinical OS are most often found in United States and in the Medical Devices industry. Merge eClinical OS is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Merge eClinical OS usage goes back as far as 6 years and 3 months.
|Company||St. Jude Medical Inc.|
|Company||Hill-Rom Holdings, Inc.|
|Tornier, Inc.||tornier-us.com||United States||50M-100M||10-50|
|St. Jude Medical Inc.||sjm.com||United States||>1000M||>10000|
|Hill-Rom Holdings, Inc.||hill-rom.com||United States||>1000M||50-200|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, Merge eClinical OS has a market share of about 0.1%. Other major and competing products in this category include:
Merge eClinical OS is an unified platform designed to help clients manage and run studies faster and more cost effectively. Users benefit from the convenience of one operating platform with clinical trial capabilities that can be mixed and matched to build a solid foundation for each trial environment. The system includes everything needed to design, deploy, and manage clinical trials - from Electronic Data Capture to Randomization to Endpoint and Adjudication Management, and much more.
Looking at Merge eClinical OS customers by industry, we find that Medical Devices (21%), Pharmaceuticals (10%), Hospital & Health Care (10%), Research (8%), Higher Education (6%) and Biotechnology (6%) are the largest segments.
91% of Merge eClinical OS customers are in United States.
Of all the customers that are using Merge eClinical OS, 12% are small (<50 employees), 26% are medium-sized and 47% are large (>1000 employees).
Of all the customers that are using Merge eClinical OS, 26% are small (<$50M), 14% are medium-sized and 41% are large (>$1000M).